10 Oct 2022
Victoire Viannay at Aktieportföljen Live
Tomorrow, you have the opportunity to listen to Fluicell’s CEO Victoire Viannay talk about Fluicell’s mission to change the face of medicine from the ground up through precision research tools, tissue-based disease models for drug development and regenerative medicine. Make sure to join us tomorrow to hear how Fluicell will advance across multiple araeas in the coming years.
Update 2022-10-17: A recorded version of Victoire’s presentation with subtitles in Swedish is no available here: